Cargando…
Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
BACKGROUND: The purpose of this study was to assess the in vivo ability of glucosaminic acid-cobalt (II) chelate to reduce glycemia. METHODS: Different concentrations of chelate solution were administrated to mice with diabetes induced by streptozotocin. RESULTS: Daily oral administration of chelate...
Autores principales: | Talba, Tahirou, Shui, Xia Wen, Cheng, Qinyuan, Tian, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138145/ https://www.ncbi.nlm.nih.gov/pubmed/21779145 http://dx.doi.org/10.2147/DMSO.S18025 |
Ejemplares similares
-
Chitosan Modification and Pharmaceutical/Biomedical Applications
por: Zhang, Jiali, et al.
Publicado: (2010) -
Antihyperlipidemic and antidiabetic effects of umbelliferone in streptozotocin diabetic rats.
por: Ramesh, B., et al.
Publicado: (2005) -
Antidiabetic activity of ethanolic extract of Cyperus rotundus rhizomes in streptozotocin-induced diabetic mice
por: Singh, Pradeep, et al.
Publicado: (2015) -
Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics – synthesis and properties
por: Stefaniak, Joanna, et al.
Publicado: (2022) -
Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic Mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2019)